Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever
This study has been completed.
Study NCT00063089   Information provided by Nabi Biopharmaceuticals
First Received: June 19, 2003   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Staphylococcal Infections
Additional conditions recognized in this trial
Bacteremia
Communicable Diseases
Infection
More general conditions related to this trial
Bacterial Infections
Gram-Positive Bacterial Infections
Inflammation
Pathologic Processes
Sepsis
Systemic Inflammatory Response Syndrome
Additional drug interventions recognized in this trial
Antibodies
Immunoglobulins
Immunoglobulins, Intravenous
Rho(D) Immune Globulin
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Nabi Biopharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services